Signifor LAR 40 MG

Ended Awarded Last action

Contract number
36C24525N0246
Awardee
Awarding agency
Obligated
$10,811

Award facts

Contract value 100% obligated
$10,811.24 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bartlett, TN 38134, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Department of Veterans Affairs (VA) awarded a delivery order contract to Recordati Rare Diseases Inc., a division of the international pharmaceutical company Recordati Group, for the provision of Signifor LAR 40 mg. The order, valued at $10,811.24, is being delivered under Recordati's Federal Supply Schedule (FSS-61-IB) contract with the VA, a five-year, $15.6 million indefinite-delivery vehicle established in April 2021. The contract does not include a set-aside designation, reflecting the specialized nature of Recordati's rare disease pharmaceuticals. The delivery order is being fulfilled to support VA medical facilities, primarily within Veterans Integrated Service Networks (VISNs) 5 and 20, which cover regions in Tennessee, Kentucky, and the Pacific Northwest. Signifor LAR is an orphan drug used to treat Cushing's disease and acromegaly, two rare endocrine disorders, highlighting Recordati's focus on providing specialized treatments for veterans with uncommon medical conditions.

Quick answers

Who was awarded contract 36C24525N0246?

36C24525N0246 was awarded to Recordati Rare Diseases Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 16, 2024.

How much is contract 36C24525N0246 worth?

The government has obligated $10,811 on 36C24525N0246.

Is contract 36C24525N0246 an order under another contract?

Yes. 36C24525N0246 is a delivery order under 36F79721D0141, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24525N0246 competed?

The extent of competition for 36C24525N0246 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award